Muscle Loss Impacts Survival in Advanced Esophageal Cancer
Excessive muscle loss during neoadjuvant therapy significantly predicts survival outcomes in locally advanced esophageal squamous cell carcinoma.
Newsletter
Every new paper in this field, in your inbox.
Excessive muscle loss during neoadjuvant therapy significantly predicts survival outcomes in locally advanced esophageal squamous cell carcinoma.
First-line immune checkpoint inhibitor therapy for esophageal cancer recurrence shows no advantage based on prior adjuvant nivolumab treatment.
Diagnostic endoscopy for gastric cancer is underused, leading to late-stage diagnoses and worse survival rates.
Endoscopic submucosal dissection (ESD) can be a viable option for patients with esophageal squamous high-grade dysplasia and early squamous cell carcinoma, challenging the conventional referral for surgical intervention.
Minimally invasive strategies are transforming achalasia management.
Log odds of positive lymph nodes classification enhances survival predictions in duodenal adenocarcinoma, crucial for surgical decision-making.
A study of 803 patients shows esophageal basaloid squamous cell carcinoma (EBSCC) has a similar overall survival to conventional esophageal squamous cell carcinoma (ESCC) post-surgery, despite unique challenges.
Total gastrectomy patients experience slower recovery and greater symptom burden compared to other types of gastrectomy.
New strategies in achalasia management are improving surgical and endoscopic outcomes for better patient care.
A new laparoscopic approach for treating duodenal perforations could reshape surgical practices.